Global Basal cell Carcinoma Therapeutics Market 2018-2022
- Published: Nov 2018
- Pages: 102
- SKU: IRTNTR23588
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
The global basal cell carcinoma therapeutics market is predicted to witness a rapid growth over the next five years boosted by the advancements in the field of oncology research. Wondering how to make the most of this booming basal cell carcinoma therapeutics industry? Technavio’s extensive industry research report offers a detailed insight that will allow you to take full advantage of the opportunities available to you. This study provides an in-depth analysis of the market by considering the evolving demographics and consumer behavior in the global basal cell carcinoma therapeutics market. It also examines the competitive landscape and some key basal cell carcinoma therapeutic companies that include Bausch Health, Biofrontera, and F. Hoffmann-La Roche.
Want to get a preview about what to expect from Technavio’s market research report? Check out the latest facts about the basal cell carcinoma therapeutics industry
The global basal cell carcinoma therapeutics market is forecasted to grow at a CAGR of almost 6% during the period of the forecast
Basal cell carcinoma therapeutics industry growth is expected to accelerate over the next five years, driven by heavy investments to develop a strong R&D department for basal cell carcinoma treatment. Cancer is considered one of the most common causes of death across the globe, and the prevalence of cancer has witnessed a rapid surge in the past few years. According to a research article published by the American Society of Clinical Oncology (ASCO), around 14 million people are predicted to develop cancer in 2018, and almost nine people die of cancer every year. The growing rate of incidence of cancer has resulted in a growing need to develop more effective basal cell carcinoma treatment, which is expected to contribute to the growth of the global basal cell carcinoma therapeutics market. Technavio’s basal cell carcinoma therapeutics industry analysis reveals promising markets around the world.
Want a bigger picture? Get a free sample of this report now!
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Americas will drive the largest incremental growth for the global basal cell carcinoma therapeutics market
About 44% of the incremental growth in the global basal cell carcinoma therapeutics market will be driven by the Americas, followed by EMEA and APAC making reasonable contributions to the market growth during the period of forecast. Furthermore, the Americas held the dominant share of more than half of the global basal cell carcinoma therapeutics market towards the end of 2017. Factors such as the rising prevalence of basal cell carcinoma, a well-defined healthcare infrastructure, and the growing number of initiatives taken by the US government are expected to drive the growth of the market in the region. However, APAC is expected to display the fastest rate of growth during the forecasted period, while EMEA will register a higher CAGR than the Americas over the next five years.
Get more value with Technavio’s subscription platform! Gain easy access to all Technavio’s reports, along with on-demand services. Start your 14-day FREE trial
Bausch Health, Biofrontera, and F. Hoffmann-La Roche are among the leading basal cell carcinoma therapeutic companies
The global basal cell carcinoma therapeutics market was marginally concentrated at the end of 2017, with the presence of a few international and regional basal cell carcinoma therapeutic companies who offer all the currently approved therapeutics for the treatment of basal cell carcinoma. Some of the established pharmaceutical companies and various government organizations are investing heavily in the R&D of novel therapies, which is currently dominated by biologic molecules due to their high efficacy. Many international and regional basal cell carcinoma therapeutic companies are vying for their share of the global basal cell carcinoma therapeutics market, and players must differentiate themselves to gain vital traction over their peers.
This report offers a complete analysis of several basal cell carcinoma therapeutic companies, including:
- Bausch Health
- Biofrontera
- F. Hoffmann-La Roche
- Mylan
- Sun Pharmaceutical
Want to dial in on a specific region or segment? We can help! Our analysts can customize this report to meet your requirements. Get in touch
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: DISEASE OVERVIEW
- Basal cell carcinoma
PART 05: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 06: MARKET SIZING
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
PART 07: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 08: PIPELINE
PART 09: MARKET SEGMENTATION BY ROA
- Segmentation by RoA
- Comparison by RoA
- Topical RoA – Market size and forecast 2017-2022
- Oral RoA – Market size and forecast 2017-2022
- Market opportunity by RoA
PART 10: CUSTOMER LANDSCAPE
PART 11: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Americas – Market size and forecast 2017-2022
- EMEA – Market size and forecast 2017-2022
- APAC – Market size and forecast 2017-2022
- Key leading countries
- Market opportunity
PART 12: DECISION FRAMEWORK
PART 13: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 14: MARKET TRENDS
- Advancements in the field of oncology research
PART 15: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 16: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Bausch Health
- Biofrontera
- F. Hoffmann-La Roche
- Mylan
- Sun Pharmaceutical
PART 17: APPENDIX
- List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases

DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts

REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
